Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icahn School Med Mount SinaifiledCriticalIcahn School Med Mount Sinai
Publication of NZ764041ApublicationCriticalpatent/NZ764041A/en
Publication of NZ764041B2publicationCriticalpatent/NZ764041B2/en
239000003795chemical substances by applicationSubstances0.000abstract1
238000000034methodMethods0.000abstract1
Abstract
The present disclosure relates to methods for the treatment of sarcoidosis. In certain aspects and embodiments, the disclosure provides compositions containing 1,3-propanedisulfonic acid or a pharmaceutically acceptable salt thereof and/or the use of such compositions for the treatment of Sarcoidosis. In another aspect, the disclosure relates to compositions containing 1,3-propanedisulfonic acid or a pharmaceutically acceptable salt thereof plus a second active agent. In yet another aspect, the disclosure relates to kits containing agents useful for the treatment of sarcoidosis.
NZ764041A2015-04-29Use of 1,3-propanedisulfonic acid or pharmaceutically acceptable salts thereof for the treatment of Sarcoidosis
NZ764041B2
(en)